Editas Medicine
(EDIT)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2018 | 12-2017 | 09-2017 | 06-2017 | 03-2017 | |
| Sales | 3,927 | 3,667 | 6,282 | 3,097 | 682 |
| Gross Profit | 3,927 | 3,667 | 6,282 | 3,097 | 682 |
| Operating Expenses | 35,486 | 40,109 | 33,031 | 29,212 | 31,309 |
| Operating Income | -31,559 | -36,442 | -26,749 | -26,115 | -30,627 |
| Interest Expense | -438 | -124 | 46 | 446 | 610 |
| Other Income | 182 | 129 | 196 | 122 | 140 |
| Pre-tax Income | -30,939 | -36,189 | -26,599 | -26,439 | -31,097 |
| Net Income Continuous | -30,939 | -36,189 | -26,599 | -26,439 | -31,097 |
| Net Income | $-30,939 | $-36,189 | $-26,599 | $-26,439 | $-31,097 |
| EPS Basic Total Ops | -0.67 | -0.84 | -0.64 | -0.65 | -0.85 |
| EPS Basic Continuous Ops | -0.67 | -0.84 | -0.64 | -0.65 | -0.85 |
| EPS Diluted Total Ops | -0.67 | -0.84 | -0.64 | -0.65 | -0.85 |
| EPS Diluted Continuous Ops | -0.67 | -0.84 | -0.64 | -0.65 | -0.85 |
| EBITDA(a) | $-30,808 | $-35,725 | $-26,065 | $-25,464 | $-29,996 |